$REGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENERON PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENERON PHARMACEUTICALS, INC.. Get notifications about new insider transactions in REGENERON PHARMACEUTICALS, INC. for free.
Page: < prev 1 ... 9 10 11 12 13 14 15 16 17 ... 48 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 04 2016 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 400.00 | 2,000 | 800,000 | 14,000 | 16 K to 14 K (-12.50 %) |
Apr 04 2016 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 177.82 | 2,000 | 355,640 | 16,000 | 14 K to 16 K (+14.29 %) |
Mar 21 2016 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | M | 177.82 | 2,000 | 355,640 | 3,000 | |
Mar 21 2016 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Sell | S | 375.00 | 2,000 | 750,000 | 14,000 | 16 K to 14 K (-12.50 %) |
Mar 21 2016 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Buy | M | 177.82 | 2,000 | 355,640 | 16,000 | 14 K to 16 K (+14.29 %) |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 398.38 | 300 | 119,514 | 23,353,665 | 23.4 M to 23.4 M (0.00 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 397.07 | 3,400 | 1,350,040 | 23,353,365 | 23.3 M to 23.4 M (+0.01 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 396.20 | 11,018 | 4,365,360 | 23,349,965 | 23.3 M to 23.3 M (+0.05 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 395.32 | 13,288 | 5,253,016 | 23,338,947 | 23.3 M to 23.3 M (+0.06 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 394.24 | 12,988 | 5,120,393 | 23,325,659 | 23.3 M to 23.3 M (+0.06 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 393.16 | 6,730 | 2,645,951 | 23,312,671 | 23.3 M to 23.3 M (+0.03 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 391.85 | 27,088 | 10,614,384 | 23,305,941 | 23.3 M to 23.3 M (+0.12 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 391.23 | 3,681 | 1,440,120 | 23,278,853 | 23.3 M to 23.3 M (+0.02 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 390.15 | 1,507 | 587,948 | 23,275,172 | 23.3 M to 23.3 M (+0.01 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 393.95 | 600 | 236,370 | 23,273,665 | 23.3 M to 23.3 M (0.00 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 393.27 | 7,301 | 2,871,281 | 23,273,065 | 23.3 M to 23.3 M (+0.03 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 392.37 | 14,692 | 5,764,635 | 23,265,764 | 23.3 M to 23.3 M (+0.06 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 391.36 | 33,131 | 12,966,118 | 23,251,072 | 23.2 M to 23.3 M (+0.14 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 390.47 | 14,303 | 5,584,885 | 23,217,941 | 23.2 M to 23.2 M (+0.06 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 389.48 | 6,789 | 2,644,152 | 23,203,638 | 23.2 M to 23.2 M (+0.03 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 388.30 | 2,196 | 852,707 | 23,196,849 | 23.2 M to 23.2 M (+0.01 %) | |
Feb 18 2016 | REGN | REGENERON PHARMACE ... | Sanofi | Buy | P | 387.43 | 2,145 | 831,034 | 23,194,653 | 23.2 M to 23.2 M (+0.01 %) | |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 472.64 | 3,563 | 1,684,020 | 23,192,508 | 23.2 M to 23.2 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 471.56 | 3,600 | 1,697,622 | 23,188,945 | 23.2 M to 23.2 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 470.64 | 7,204 | 3,390,522 | 23,185,345 | 23.2 M to 23.2 M (+0.03 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 469.71 | 14,169 | 6,655,261 | 23,178,141 | 23.2 M to 23.2 M (+0.06 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 468.47 | 5,082 | 2,380,737 | 23,163,972 | 23.2 M to 23.2 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 467.66 | 4,901 | 2,292,010 | 23,158,890 | 23.2 M to 23.2 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 466.26 | 3,608 | 1,682,273 | 23,153,989 | 23.2 M to 23.2 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 465.50 | 8,002 | 3,724,929 | 23,150,381 | 23.1 M to 23.2 M (+0.03 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 464.41 | 4,148 | 1,926,377 | 23,142,379 | 23.1 M to 23.1 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 463.17 | 2,759 | 1,277,892 | 23,138,231 | 23.1 M to 23.1 M (+0.01 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 462.23 | 4,941 | 2,283,860 | 23,135,472 | 23.1 M to 23.1 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 461.41 | 3,563 | 1,644,014 | 23,130,531 | 23.1 M to 23.1 M (+0.02 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 460.12 | 2,500 | 1,150,289 | 23,126,968 | 23.1 M to 23.1 M (+0.01 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 458.00 | 3,100 | 1,419,785 | 23,124,468 | 23.1 M to 23.1 M (+0.01 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 457.18 | 3,220 | 1,472,134 | 23,121,368 | 23.1 M to 23.1 M (+0.01 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 455.68 | 2,164 | 986,086 | 23,118,148 | 23.1 M to 23.1 M (+0.01 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 454.60 | 2,407 | 1,094,215 | 23,115,984 | 23.1 M to 23.1 M (+0.01 %) |
Jan 14 2016 | REGN | REGENERON PHARMACE ... | Sanofi | 10% Owner | Buy | P | 453.89 | 5,007 | 2,272,633 | 23,113,577 | 23.1 M to 23.1 M (+0.02 %) |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Gift | G | 0.00 | 1,000 | 0 | 17,349 | 18.3 K to 17.3 K (-5.45 %) |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | GOLDSTEIN JOSEPH L | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | RYAN ARTHUR F | Director | Gift | G | 0.00 | 6,000 | 0 | 41,500 | 47.5 K to 41.5 K (-12.63 %) |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | Tessier-Lavigne Marc | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | BAKER CHARLES A | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Jan 06 2016 | REGN | REGENERON PHARMACE ... | POON CHRISTINE A | Director | Option Exercise | A | 520.01 | 9,212 | 4,790,332 | 9,212 | |
Dec 29 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 3,954 | 205,727 | 0 | |
Dec 29 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Sell | S | 552.08 | 3,954 | 2,182,924 | 6,866 | 10.8 K to 6.9 K (-36.54 %) |
Dec 29 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 3,954 | 205,727 | 10,820 | 6.9 K to 10.8 K (+57.59 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | A | 555.67 | 25,500 | 14,169,585 | 25,500 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Option Exercise | M | 24.00 | 4,000 | 96,000 | 166 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Aberman Michael S | SVP Strategy Invest ... | Buy | M | 24.00 | 4,000 | 96,000 | 16,498 | 12.5 K to 16.5 K (+32.01 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Landry Robert E | SVP Finance & CFO | Option Exercise | A | 555.67 | 28,900 | 16,058,863 | 28,900 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | LAROSA JOSEPH J | SVP General Counsel ... | Option Exercise | A | 555.67 | 28,900 | 16,058,863 | 28,900 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | A | 555.67 | 3,800 | 2,111,546 | 3,800 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | McCorkle Douglas S | VP Controller and A ... | Buy | M | 52.03 | 1,921 | 99,950 | 6,866 | 4.9 K to 6.9 K (+38.85 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | A | 555.67 | 25,000 | 13,891,750 | 25,000 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Powchik Peter | SVP Clinical Develo ... | Buy | M | 52.03 | 1,921 | 99,950 | 17,742 | 15.8 K to 17.7 K (+12.14 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | SCHLEIFER LEONARD S | President & CEO | Option Exercise | A | 555.67 | 172,723 | 95,976,989 | 172,723 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | A | 555.67 | 68,638 | 38,140,077 | 68,638 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 52.03 | 1,921 | 99,950 | 27,594 | 25.7 K to 27.6 K (+7.48 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 555.67 | 40,000 | 22,226,800 | 40,000 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | A | 555.67 | 40,000 | 22,226,800 | 40,000 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 52.03 | 1,921 | 99,950 | 1,921 | 0 to 1.9 K |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | A | 555.67 | 146,815 | 81,580,691 | 146,815 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Buy | M | 52.03 | 1,921 | 99,950 | 501,921 | 500 K to 501.9 K (+0.38 %) |
Dec 18 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Option Exercise | A | 555.67 | 92,123 | 51,189,987 | 92,123 | |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Option Exercise | M | 177.82 | 3,000 | 533,460 | 12,000 | |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 547.50 | 1,199 | 656,453 | 0 | 1.2 K to 0 (-100.00 %) |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 546.36 | 1,003 | 547,999 | 1,199 | 2.2 K to 1.2 K (-45.55 %) |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 545.41 | 598 | 326,155 | 2,202 | 2.8 K to 2.2 K (-21.36 %) |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 544.03 | 100 | 54,403 | 2,800 | 2.9 K to 2.8 K (-3.45 %) |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Sell | S | 543.55 | 100 | 54,355 | 2,900 | 3 K to 2.9 K (-3.33 %) |
Dec 11 2015 | REGN | REGENERON PHARMACE ... | BROWN MICHAEL S | Director | Buy | M | 177.82 | 3,000 | 533,460 | 3,000 | 0 to 3 K |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Gift | G | 0.00 | 1,612 | 0 | 567,976 | 569.6 K to 568 K (-0.28 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 555.26 | 1,900 | 1,054,994 | 500,000 | 501.9 K to 500 K (-0.38 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 554.58 | 1,101 | 610,593 | 501,900 | 503 K to 501.9 K (-0.22 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 553.32 | 1,600 | 885,312 | 503,001 | 504.6 K to 503 K (-0.32 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 552.54 | 3,625 | 2,002,958 | 504,601 | 508.2 K to 504.6 K (-0.71 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 551.43 | 4,992 | 2,752,739 | 508,226 | 513.2 K to 508.2 K (-0.97 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 550.47 | 6,390 | 3,517,503 | 513,218 | 519.6 K to 513.2 K (-1.23 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 549.57 | 4,407 | 2,421,955 | 519,608 | 524 K to 519.6 K (-0.84 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 548.49 | 3,780 | 2,073,292 | 524,015 | 527.8 K to 524 K (-0.72 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 547.45 | 914 | 500,369 | 527,795 | 528.7 K to 527.8 K (-0.17 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 546.36 | 3,038 | 1,659,842 | 528,709 | 531.7 K to 528.7 K (-0.57 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 545.51 | 5,611 | 3,060,857 | 531,747 | 537.4 K to 531.7 K (-1.04 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 544.52 | 4,290 | 2,335,991 | 537,358 | 541.6 K to 537.4 K (-0.79 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 543.57 | 602 | 327,229 | 541,648 | 542.3 K to 541.6 K (-0.11 %) |
Dec 04 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 542.72 | 1,098 | 595,907 | 542,250 | 543.3 K to 542.3 K (-0.20 %) |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Option Exercise | M | 19.69 | 3,000 | 59,070 | 7,000 | |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 500 | 290,000 | 4,500 | 5 K to 4.5 K (-10.00 %) |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Sell | S | 580.00 | 3,000 | 1,740,000 | 112,772 | 115.8 K to 112.8 K (-2.59 %) |
Nov 20 2015 | REGN | REGENERON PHARMACE ... | SING GEORGE L | Director | Buy | M | 19.69 | 3,000 | 59,070 | 115,772 | 112.8 K to 115.8 K (+2.66 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 455 | 0 | 153,935 | 154.4 K to 153.9 K (-0.29 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 1,731 | 0 | 332,880 | 334.6 K to 332.9 K (-0.52 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 586.73 | 3,474 | 2,038,300 | 334,611 | 338.1 K to 334.6 K (-1.03 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 587.58 | 3,539 | 2,079,446 | 338,085 | 341.6 K to 338.1 K (-1.04 %) |
Nov 19 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 588.40 | 10,227 | 6,017,567 | 341,624 | 351.9 K to 341.6 K (-2.91 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,486 | 168,036 | 42,195 | |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Option Exercise | M | 30.63 | 5,700 | 174,591 | 47,681 | |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 557.14 | 1,223 | 681,382 | 0 | 1.2 K to 0 (-100.00 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 556.00 | 1,000 | 556,000 | 1,223 | 2.2 K to 1.2 K (-44.98 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 554.39 | 2,000 | 1,108,780 | 2,223 | 4.2 K to 2.2 K (-47.36 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 552.50 | 50 | 27,625 | 4,223 | 4.3 K to 4.2 K (-1.17 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Sell | S | 551.45 | 850 | 468,733 | 4,273 | 5.1 K to 4.3 K (-16.59 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,674 | 1,496,076 | 5,123 | 7.8 K to 5.1 K (-34.30 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 300 | 167,847 | 7,797 | 8.1 K to 7.8 K (-3.71 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,486 | 168,036 | 8,097 | 2.6 K to 8.1 K (+210.11 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 2,778 | 1,554,263 | 2,611 | 5.4 K to 2.6 K (-51.55 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Payment of Exercise | F | 559.49 | 311 | 174,001 | 5,389 | 5.7 K to 5.4 K (-5.46 %) |
Nov 10 2015 | REGN | REGENERON PHARMACE ... | Van Plew Daniel P | SVP & General Mgr I ... | Buy | M | 30.63 | 5,700 | 174,591 | 5,700 | 0 to 5.7 K |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 30.63 | 75,000 | 2,297,250 | 46,736 | |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Option Exercise | M | 21.25 | 25,000 | 531,250 | 20,295 | |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.41 | 900 | 507,069 | 22,029 | 22.9 K to 22 K (-3.93 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.31 | 5,607 | 3,152,872 | 22,929 | 28.5 K to 22.9 K (-19.65 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 561.36 | 500 | 280,680 | 28,536 | 29 K to 28.5 K (-1.72 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 560.31 | 3,900 | 2,185,209 | 29,036 | 32.9 K to 29 K (-11.84 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 559.26 | 1,500 | 838,890 | 32,936 | 34.4 K to 32.9 K (-4.36 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 558.37 | 9,694 | 5,412,839 | 34,436 | 44.1 K to 34.4 K (-21.97 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 564.19 | 2,100 | 1,184,799 | 44,130 | 46.2 K to 44.1 K (-4.54 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 563.43 | 8,345 | 4,701,823 | 46,230 | 54.6 K to 46.2 K (-15.29 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Sell | S | 562.37 | 9,555 | 5,373,445 | 54,575 | 64.1 K to 54.6 K (-14.90 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 13,312 | 7,556,291 | 64,130 | 77.4 K to 64.1 K (-17.19 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 935 | 530,734 | 77,442 | 78.4 K to 77.4 K (-1.19 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 21.25 | 25,000 | 531,250 | 78,377 | 53.4 K to 78.4 K (+46.84 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 39,605 | 22,480,986 | 53,377 | 93 K to 53.4 K (-42.59 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Payment of Exercise | F | 567.63 | 4,047 | 2,297,199 | 92,982 | 97 K to 93 K (-4.17 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Buy | M | 30.63 | 75,000 | 2,297,250 | 97,029 | 22 K to 97 K (+340.46 %) |
Nov 09 2015 | REGN | REGENERON PHARMACE ... | STAHL NEIL | EVP Research and De ... | Gift | G | 0.00 | 1,000 | 0 | 16,405 | 17.4 K to 16.4 K (-5.75 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 414 | 0 | 154,390 | 154.8 K to 154.4 K (-0.27 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 462 | 0 | 154,804 | 155.3 K to 154.8 K (-0.30 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Gift | G | 0.00 | 511 | 0 | 155,266 | 155.8 K to 155.3 K (-0.33 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 580.23 | 3,985 | 2,312,217 | 351,851 | 355.8 K to 351.9 K (-1.12 %) |
Nov 04 2015 | REGN | REGENERON PHARMACE ... | VAGELOS P ROY | Chairman of the Boa ... | Sell | S | 580.18 | 13,257 | 7,691,446 | 355,836 | 369.1 K to 355.8 K (-3.59 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Option Exercise | M | 11.64 | 182,818 | 2,128,002 | 0 | |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 580.29 | 400 | 232,116 | 543,348 | 543.7 K to 543.3 K (-0.07 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 579.53 | 1,500 | 869,295 | 543,748 | 545.2 K to 543.7 K (-0.28 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 578.73 | 268 | 155,100 | 545,248 | 545.5 K to 545.2 K (-0.05 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 577.58 | 1,996 | 1,152,850 | 545,516 | 547.5 K to 545.5 K (-0.36 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 576.48 | 865 | 498,655 | 547,512 | 548.4 K to 547.5 K (-0.16 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 575.64 | 2,441 | 1,405,137 | 548,377 | 550.8 K to 548.4 K (-0.44 %) |
Nov 03 2015 | REGN | REGENERON PHARMACE ... | YANCOPOULOS GEORGE | President Regeneron ... | Sell | S | 574.55 | 2,693 | 1,547,263 | 550,818 | 553.5 K to 550.8 K (-0.49 %) |